Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.
Sana Biotechnology, Inc. (SANA) had 10 insider filings in the last 90 days, with the most recent on 2026-08-27. The full record for SANA runs to 24 Form 4 filings, the earliest from 2024-10-09. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying SANA stock?
No insider purchases of SANA were filed in the last 90 days.
How many insiders are selling SANA stock?
No insider sales of SANA were filed in the last 90 days.
Where can I see SANA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks SANA Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow SANA insider buys?
Create a free InsiderAlpha account and press Watch on this page to add SANA to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
